Points to Consider in the Foundation of Multidisciplinary Units for Psoriatic Arthritis: A Delphi Study and a Systematic Review of the Literature. Issue 12 (January 2017)

• Record Type: Journal Article
• Authors: Gratacos-Masmitja, Jordi; Luelmo-Aguilar, Jesus; Zarco-Montejo, Pedro; Botella-Estrada, Rafael; Carrizosa-Esquivel, Ana; Garcia-Vivar, Maria; Perez-Barrio, Silvia; Roman-Ivorra, Jose; Ruiz-Montesino, Maria; Lopez-Estebaranz, Jose
• Is Part Of: Advances in therapy. Volume 33:Issue 12(2016)
• Page Start: 2150
• Page End: 2159
• Publication Date: 2017-01
• Subjects: Biological therapy -- Consensus development -- Dermatology -- Organizations -- Hospital units -- Multidisciplinary care -- Psoriasis -- Psoriatic arthritis -- Rheumatology; Diagnosis -- Periodicals; Therapeutics -- Periodicals; 615.5
• DOI: 10.1007/s12325-016-0429-z
• Languages: English
• ISSNs: 0741-238X

Abstract

Abstract Introduction In numerous clinical practice guidelines, emphasis is placed on the need for coordinated care of psoriatic arthritis (PsA) between rheumatologists and the objective was to develop experience-based points to consider facilitating the implementation of multidisciplinary units (Dermatology/Rheumatology) for the management of patients with PsA. Methods A scientific committee of rheumatology and dermatology experts in the management of PsA, and with experience in joint care, discussed the critical aspects of multidisciplinary PsA Units. The discussion became the basis for a Delphi survey in two rounds submitted to a panel of 24 specialists in rheumatology and dermatology not involved in PsA units. The statements and practices that reached a consensus were summarized and further elaborated. Results After two Delphi rounds, agreement was reached for 49 of the 50 proposed statements. These included a justification of the units, objectives, and utilities, as well as operational aspects of the units, such as the minimal and ideal premises, referral criteria, and necessary resources. The statements were compiled in 11 points to consider. Conclusions This consensus offers some points to consider, including premises and recommendations, for the development of specialized Units in the management of PsA based on expert opinion. We trust these guidelines may facilitate their implementation in the future. Funding Pfizer.